CD29 Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in the Treatment of a Pigmented Melanoma Model

The authors investigated the efficacy of CD29- and CD44-targeted NIR-PIT (CD29-PIT and CD44-PIT, respectively) in the B16 melanoma model, which was highly pigmented.